+1 to mike.trainer_LA. Especially the point about "Re: Singapore HSA regulations 12 — the ..." — I have seen the same in my own experience with Singapore HSA regulations.
Want to share my personal experience related to Singapore HSA regulations 12 since I think it might help others in a similar situation.
I started my GLP-1 journey in October 2024 at 246 lbs with prediabetes and hypertension. My endocrinologist prescribed semaglutide 0.25mg to start.
Now, 14 months later: I am down 51 lbs, my labs have normalized, and I am off 2 of my 3 medications. The Singapore HSA aspect specifically was something that made a big difference in my journey.
This community helped me every step of the way.
Dr.CardioMD — that is really helpful context on Singapore HSA regulations. Follow-up question: did you experience any side effects during this phase?
I am in a similar situation (about to start) and trying to set realistic expectations.
Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.
View ResultsTo answer ricardo_MIA's question specifically:
From a clinical standpoint, Singapore HSA regulations 12 is something I discuss with patients regularly.
The short answer: discuss this specific situation with your prescribing provider.
The longer answer involves weighing the risk-benefit ratio for your individual situation, which I am happy to elaborate on if helpful.